Ozurdex (dexamethasone)

DRUG2 trials

Sponsors

University of Sydney, Rigshospitalet, Denmark

Conditions

DiabetesDiabetic Macular EdemaDiabetic Macular OedemaDiabetic RetinopathyInformed ConsentPreference, Patient

Phase 2

Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema

CompletedNCT01787669

University of SydneyDiabetes, Diabetic Macular Edema, Diabetic Macular Oedema +1

Start: 2013-06-30End: 2017-10-31Updated: 2018-11-13

Unknown Phase

Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections

RecruitingNCT06894017

Rigshospitalet, DenmarkInformed Consent, Preference, Patient

Start: 2025-01-13End: 2026-01-31Target: 200Updated: 2025-07-24